Related Experiment Videos
Intoxication with sodium monofluoroacetate (compound 1080)
Renee F Robinson1, Jill R Griffith, William R Wolowich
1Pediatric Pharmacotherapy/NIH Clinical Research K30 Program, College of Pharmacy, The Ohio State University, Childrens Research Institute, The Central Ohio Poison Control Center, Columbus 43210, USA.
Summary
Intentional ingestion of sodium monofluoroacetate (SMFA), a banned rodenticide, caused severe toxicity, including seizures and anion gap metabolic acidosis. This case highlights the importance of recognizing SMFA poisoning despite its restricted use.
Area of Science:
- Toxicology
- Emergency Medicine
- Clinical Case Reports
Background:
- Sodium monofluoroacetate (SMFA) is a highly toxic compound previously used as a rodenticide in the U.S. and banned in 1972.
- Intentional ingestion of SMFA is rare, with this case representing the first reported instance in the U.S. in over 15 years.
Observation:
- A 47-year-old male presented with a tonic-clonic seizure following intentional SMFA ingestion.
- The patient exhibited progressive neurological decline, requiring intubation and mechanical ventilation.
- Clinical course included agitation, hypertension, and anion gap metabolic acidosis.
Findings:
- The patient demonstrated severe central nervous system toxicity and metabolic derangement consistent with SMFA poisoning.
- Despite the severity of initial symptoms, the patient experienced a remarkable recovery without apparent neurological sequelae.
- Recovery occurred over several days with supportive care, including mechanical ventilation.
Implications:
- This case underscores the persistent risk of SMFA toxicity, even after its ban, emphasizing the need for heightened awareness among healthcare professionals.
- Early recognition and management of SMFA poisoning are crucial for patient survival and preventing long-term complications.
- The case highlights SMFA's potential to induce severe anion gap metabolic acidosis and profound neurological impairment.